Oyster Point Pharma reports topline phase I results with OC-01 nasal spray for dry eye Nov. 25, 2019 No Comments
AGTC announces second ophthalmology program, reports promising preclinical data on dual AAV Nov. 7, 2019 No Comments
Iveric Bio's phase IIb study of Zimura for geographic atrophy in dry AMD meets primary endpoint Oct. 29, 2019 No Comments
Preclinical results presented of a gene therapy for the treatment of retinitis pigmentosa Oct. 28, 2019 No Comments
Sanofi begins phase I/II study of SAR-439483 in LCA caused by GUCY2D mutations Oct. 16, 2019 No Comments
ReNeuron announces phase I/IIa data on hRPC stem cell therapy in retinitis pigmentosa Oct. 14, 2019 No Comments
Eyevensys provides initial data from phase I/II study of EYS-606 for noninfectious uveitis Oct. 14, 2019 No Comments